MX2023004418A - Capsulas de gel blando de liberacion modificada. - Google Patents

Capsulas de gel blando de liberacion modificada.

Info

Publication number
MX2023004418A
MX2023004418A MX2023004418A MX2023004418A MX2023004418A MX 2023004418 A MX2023004418 A MX 2023004418A MX 2023004418 A MX2023004418 A MX 2023004418A MX 2023004418 A MX2023004418 A MX 2023004418A MX 2023004418 A MX2023004418 A MX 2023004418A
Authority
MX
Mexico
Prior art keywords
dependent
controlled release
modified release
softgel capsules
active agent
Prior art date
Application number
MX2023004418A
Other languages
English (en)
Spanish (es)
Inventor
Karunakar Sukuru
Qi Fang
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of MX2023004418A publication Critical patent/MX2023004418A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2023004418A 2020-10-16 2021-10-15 Capsulas de gel blando de liberacion modificada. MX2023004418A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063092762P 2020-10-16 2020-10-16
PCT/US2021/071900 WO2022082222A1 (en) 2020-10-16 2021-10-15 Modified release softgel capsules

Publications (1)

Publication Number Publication Date
MX2023004418A true MX2023004418A (es) 2023-05-04

Family

ID=81208677

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023004418A MX2023004418A (es) 2020-10-16 2021-10-15 Capsulas de gel blando de liberacion modificada.

Country Status (13)

Country Link
US (1) US20230390210A1 (cg-RX-API-DMAC10.html)
EP (1) EP4228597A4 (cg-RX-API-DMAC10.html)
JP (1) JP7897229B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230088388A (cg-RX-API-DMAC10.html)
CN (1) CN116322655A (cg-RX-API-DMAC10.html)
AR (1) AR123805A1 (cg-RX-API-DMAC10.html)
AU (1) AU2021362248A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023006154A2 (cg-RX-API-DMAC10.html)
CA (1) CA3194160A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023005753A2 (cg-RX-API-DMAC10.html)
IL (1) IL301715A (cg-RX-API-DMAC10.html)
MX (1) MX2023004418A (cg-RX-API-DMAC10.html)
WO (1) WO2022082222A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117705978A (zh) * 2023-12-14 2024-03-15 河南泰丰生物科技有限公司 一种四烯甲奈醌软胶囊溶出曲线的测定方法
CN122458978A (zh) * 2023-12-22 2026-07-24 花王株式会社 胶囊剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151127A (ja) * 1984-12-25 1986-07-09 Meiji Milk Prod Co Ltd ビフイズス菌含有ソフトカプセルの製造方法
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US7842307B2 (en) * 2001-08-06 2010-11-30 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
DE60238269D1 (de) * 2001-11-22 2010-12-23 Morishita Jintan Co Nicht-gelatinöse Kapseln
KR100575199B1 (ko) * 2003-01-24 2006-05-02 알앤피코리아주식회사 연질 캡슐의 블루밍 방지를 위한 가소제 조성물 및 이를함유한 피막
IT1401313B1 (it) * 2010-08-05 2013-07-18 Perfetti Van Melle Spa Caramelle gelatinose con ripieno fluido e metodo di ottenimento
US20120301546A1 (en) * 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
GB201304662D0 (en) * 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319792D0 (en) * 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
WO2015200149A1 (en) 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
US9877971B2 (en) * 2015-06-15 2018-01-30 Banner Life Sciences Llc Soft lozenges comprising corticosteroids
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
AU2019362883B2 (en) * 2018-10-16 2025-07-31 Bayer Healthcare Llc Softgels with solid or gel-like polymeric fill matrix
EP4674410A3 (en) * 2019-10-28 2026-03-18 R.P. Scherer Technologies, LLC Delayed release softgel capsules in higher ph environment

Also Published As

Publication number Publication date
CO2023005753A2 (es) 2023-05-29
IL301715A (en) 2023-05-01
AR123805A1 (es) 2023-01-11
KR20230088388A (ko) 2023-06-19
TW202228656A (zh) 2022-08-01
JP7897229B2 (ja) 2026-07-29
CN116322655A (zh) 2023-06-23
WO2022082222A1 (en) 2022-04-21
JP2023547062A (ja) 2023-11-09
CA3194160A1 (en) 2022-04-21
BR112023006154A2 (pt) 2023-05-09
AU2021362248A9 (en) 2024-05-02
EP4228597A4 (en) 2024-10-02
US20230390210A1 (en) 2023-12-07
AU2021362248A1 (en) 2023-06-01
EP4228597A1 (en) 2023-08-23

Similar Documents

Publication Publication Date Title
MX2010007609A (es) Formulacion de capsula.
WO2008132712A3 (en) Combination pharmaceutical compositions
EP4327797A3 (en) Multi phase soft gel capsules, apparatus and method thereof
PH12014502191A1 (en) Capsule disintegrable in large-intestine-specific manner
WO2017171535A8 (en) Compositions
MY190392A (en) A delayed release drug formulation
BR112021024375A2 (pt) Cápsulas de softgel de liberação retardada
JP2010523553A5 (cg-RX-API-DMAC10.html)
WO2011101866A3 (en) Gastric retention formulation containing baclofen
WO2011116139A3 (en) Improved pharmaceutical compositions comprising cck- 8 and methods of delivery
PE20130574A1 (es) Nuevas formas de dosificacion de liberacion modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa
WO2011111027A3 (en) Oral dispersible delayed release tablet formulation
WO2010103365A3 (en) Sustained release composition of therapeutic agent
WO2010020856A3 (en) Rate modulated delivery of drugs from a composite delivery system
FI3324948T3 (fi) Monikerroksisia farmaseuttisesti aktiivista yhdistettä vapauttavia mikropartikkeleita nestemäisessä annosmuodossa
WO2011140446A3 (en) Pharmaceutical formulations
MX2022015160A (es) Capsulas de gelatina blanda de liberacion retardada.
NZ714517A (en) Delayed release cysteamine bead formulation
EP4674410A3 (en) Delayed release softgel capsules in higher ph environment
WO2012020301A3 (en) Oral controlled release pharmaceutical compositions of blonanserin
PH12016500693A1 (en) Slow-release solid oral compositions
IL177243A0 (en) Extended release coated minitablets of venlafaxine hydrochloride
PE20120647A1 (es) Composiciones y metodos para el tratamiento y prevencion de la enfermedad cardiovascular
MX346316B (es) Formulacion farmaceutica o nutraceutica.
CO2023005753A2 (es) Cápsulas de gelatina blanda de liberación modificada